GoodsMSE preference
INJ BIOVIC 90 MG (SODIUM HYALURONATE),INJ POLATUZUMAB 140MG,Inj Anti-Hemophilic 500 UNIT (Factor-VI
Key dates
Published
24 Oct 2026, 09:10 AM IST
Bid submission starts
24 Oct 2026, 09:10 AM IST
Bid submission ends
Bids open
15 Nov 2026, 10:00 AM IST
Eligibility and documents required
Work description
153 × INJ BIOVIC 90 MG (SODIUM HYALURONATE) , INJ POLATUZUMAB 140MG , Inj Anti-Hemophilic 500 UNIT (Factor-VIII) , INJ ANTI HEMOPHILLIC FACTOR VIII 1000IU , Luspatercept powder for solution for injection 75 mg
Tender documents
- GEM-2026-B-8078939.pdfGeM bid document
Download documents here with a free account, or from the portal itself. Create free account
Tender details
- Tender ID
- GEM/2026/B/8078939
- Portal
- Government e-Marketplace (GeM)
- Tender type
- GeM Bid
- Form of contract
- Item wise evaluation
- Product category
- INJ BIOVIC 90 MG (SODIUM HYALURONATE),INJ POLATUZUMAB 140MG,Inj Anti-Hemophilic 500 UNIT (Factor-VI